Search results for "INFECTIONS"

showing 10 items of 2671 documents

Serotyping and genotyping of encapsulated Escherichia coli K1 sepsis isolates with a monoclonal IgG anti K1 antibody and K1 gene probes

1987

Among infectious diseases caused by E. coli the capsular type K1 plays a predominant role. E. coli K1 isolates account for 80% of cases of E. coli neonatal meningitis and 30% of E. coli sepsis strains. Serotyping of K1 strains has conventionally relied upon the use of K1-specific bacteriophages or serum agar methods with polyvalent anti K1 serum. In the study present here, 187 E. coli sepsis isolates have been analysed for production of the K1 antigen using K1 phages, K1 serum agar plates and Latex agglutination and ELISA using an IgG2a anti K1 monoclonal antibody. In total, 33 sepsis isolates (about 18%) were identified as K1 positive, with three of these strains proving negative in all te…

Serotypebiologymedicine.drug_classAntibodies MonoclonalEnzyme-Linked Immunosorbent Assaymedicine.disease_causeMonoclonal antibodyMicrobiologyImmunoglobulin GMicrobiologyLatex fixation testAgar plateInfectious DiseasesAntigenGenes BacterialImmunoglobulin GSepsisEscherichia colimedicinebiology.proteinHumansAntibodyEscherichia coliEscherichia coli InfectionsLatex Fixation TestsMicrobial Pathogenesis
researchProduct

Field testing of a vaccine against eel diseases caused by Vibrio vulnificus

2001

The field results of a vaccination programme against Vibrio vulnificus serovar E (biotype 2) in a Spanish eel farm are reported. A total of 9.5 million glass eels were vaccinated from January 1998 to March 2000 by prolonged immersion followed by 2 subsequent reimmunisations after 12 to 14 and 24 to 28 d, respectively. The acquired protection and the immune response against serovar E were estimated over a period of 6 mo after vaccination. A similar vaccination schedule was conducted with elvers in a Danish eel farm. In this case, the acquired protection and the immune response against serovar E and the new eel-pathogenic serovars, recently described in Denmark, were evaluated over a short te…

Serotypeendocrine systemTime Factorsanimal structuresVaccination scheduleField vaccination. vibriosisVibrio vulnificus biotype 2Eel vaccinesVibrio vulnificusAquatic Science:CIENCIAS DE LA VIDA [UNESCO]MicrobiologyFish DiseasesImmune systemVibrionaceaeAnguillidaeUNESCO::CIENCIAS DE LA VIDAAnimalsUNESCO::CIENCIAS DE LA VIDA::Biología animal (Zoología)Vibrio vaccinesEcology Evolution Behavior and SystematicsVaccination by prolonged immersionVibrioEels:CIENCIAS DE LA VIDA::Biología animal (Zoología) [UNESCO]biologyVibrio vulnificus serovar E ; Vibrio vulnificus biotype 2 ; Eel vaccines ; Vibrio vaccines ; Vaccination by prolonged immersion ; Field vaccination. vibriosisBody WeightVaccinationbiology.organism_classificationAntibodies BacterialVaccinationVibrio vulnificus serovar EVibrio InfectionsHumoral immunityBacterial Vaccines
researchProduct

Vibrio vulnificus serovar A: an emerging pathogen in European anguilliculture.

2006

The spread of the emerging pathogen Vibrio vulnificus biotype 2 serovar A in Danish anguilliculture is reported. Serovar A was originally isolated in a Spanish eel farm in 2000 and occurred in Denmark in the summer of 2004, affecting eels of 5-10 g body weight cultured in fresh water. The Danish eels showed clinical signs different from those reported for Spanish eels, such as severe haemorrhages in the head and gill region with necrosis of the soft tissues. Danish isolates were biochemically and serologically identical to Spanish serovar A strains and also highly virulent for eels by both intraperitoneal injection and immersion challenges. Vaccination with Vulnivaccine, a vaccine against V…

Serotypeendocrine systemanimal structuresVeterinary (miscellaneous)DenmarkFisheriesVirulenceVibrio vulnificusMicrobial Sensitivity TestsAquatic ScienceBody weightCommunicable Diseases EmergingMicrobiologyDisease OutbreaksEmerging pathogenFish DiseasesAnimalsSerotypingVibrio vulnificusVibrioEelsbiologyVirulenceVaccinationbiology.organism_classificationVirologyVaccinationFresh waterVibrio InfectionsBacterial VaccinesJournal of fish diseases
researchProduct

Immune Response to the 23-Valent Polysaccharide Pneumococcal Vaccine (PPV23) after the 7-Valent Conjugate Vaccine (PCV7) in Allogeneic Stem Cell Tran…

2008

Abstract Background: Pneumococcal infections are causes of death after SCT. The IDWP01 trial compared early (E) vs late (L) pneumococcal immunization after allogeneic SCT, starting either at 3, or at 9 months post-transplant with 3 doses of PCV7 given at 1 month intervals,. This study has shown that the early immunization was not inferior in the proportion of responders one month after the last PCV7 dose. In addition, all patients received one dose of PPV23 after the 3 doses of PCV7 at 12 months and 18 months in the E and L groups, respectively. The goal of this supplementary analysis was to look at the immune response to the PPV23 according to the time of its administration. Methods: 158 p…

Serotypemedicine.medical_specialtyImmunologyBiochemistryGastroenterology03 medical and health sciences0302 clinical medicineImmune systemAntigenConjugate vaccineInternal medicinemedicinebiologybusiness.industryCell BiologyHematologymedicine.disease3. Good healthVaccinationPneumococcal infectionsPneumococcal vaccine030220 oncology & carcinogenesisbiology.proteinAntibodybusiness030215 immunologyBlood
researchProduct

Infections caused by Pseudomonas aeruginosa: relatively frequent isolation of serogroup 12 from clinical specimens.

1985

Serological typing of P. aeruginosa is the most simple and reliable procedure recommended for ≪ in-house ≫ investigations and for studies of suspected outbreaks of infection by this microorganism. It is also a useful procedure in order to know serotype prevalence in a definite geografical area and to obtain indications about the more appropriate composition of polivalent anti-Pseudomonas vaccines. In the present report, we describe the relatively high frequency of isolation of serogroup 12 from patients in Palermo, Italy. Serogroup 12 is very rare in north-Europe and in the USA, and, as a consequence, it is not included in some vaccine preparations. In Palermo, strains belonging to this ser…

Serotypemedicine.medical_specialtyIsolation (health care)Pseudomonas VaccinesEpidemiologymedicine.drug_classAntibioticsBurn Unitsmedicine.disease_causeMicrobiologySerologyEpidemiologymedicineHumansSurgical Wound InfectionPseudomonas InfectionsTypingVaccines CombinedSerotypingRespiratory Tract InfectionsPseudomonas aeruginosabusiness.industryOutbreakVirologyItalyBacterial VaccinesPseudomonas aeruginosaUrinary Tract InfectionsbusinessBurnsEuropean journal of epidemiology
researchProduct

Characterization of the first extended-spectrum beta-lactamase-producing nontyphoidal Salmonella strains isolated in Tehran, Iran.

2009

The infections caused by Salmonella remain a significant public health problem throughout the world. beta-Lactams and fluoroquinolones are generally used to treat invasive Salmonella infections, but emergence and spread of antibiotic-resistant strains are being increasingly notified in many countries. In particular, detection of extended-spectrum beta-lactamases (ESBLs) in Salmonella spp. is a newly emerging threat worldwide. This study was carried out to characterize beta-lactamase-producing Salmonella strains identified in Tehran, Iran. Over the 2-year period from 2007 to 2008, 6 of 136 Salmonella isolates recovered from pediatrics patients, including three Salmonella enterica serotypes E…

Serotypemedicine.medical_specialtySalmonellamedicine.medical_treatmentMolecular Sequence DataDrug resistanceMicrobial Sensitivity TestsBiologyIranmedicine.disease_causeApplied Microbiology and BiotechnologyMicrobiologyPolymerase Chain Reactionbeta-LactamasesMicrobiologylaw.inventionSpecies SpecificitylawSalmonellaMolecular geneticsDrug Resistance Multiple BacterialmedicineHumansS. enteritidisSerotypingChildPolymerase chain reactionInfantSequence Analysis DNAbiology.organism_classificationVirologyPhenotypeAmino Acid SubstitutionSalmonella enteritidisSalmonella entericaChild PreschoolConjugation GeneticSalmonella InfectionsBeta-lactamaseAnimal Science and ZoologyGenes MDRFood ScienceFoodborne pathogens and disease
researchProduct

The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1)

2005

C1-esterase inhibitor (C1-INH) was depleted from normal human serum (NHS) at 4 degrees C by affinity chromatography with a monoclonal anti-C1-INH antibody (mAb 13 E1) coupled to CNBr-activated Sepharose 4B. The C1-INH-depleted serum (C1-INH-depl-HS) had normal levels of C1, C4, and CH 50 and C1-INH concentration was less than 10% of normal (15 microg/ml in C1-INH-depl-HS compared to 230 microg/ml in NHS). C1-auto-activation in C1-INH-depl-HS was followed by measuring C4-consumption in a haemolytic assay and by detection of activated C1s in a C1s-ELISA. After a lag phase of 10-20 min, C1-auto-activation in C1-INH depl-HS occurred and reached its maximum after 40 min at 37 degrees C. In contr…

Serummedicine.drug_classImmunologyComplement C1 Inactivator ProteinsMonoclonal antibodyNeutralizationSepharoseMiceAffinity chromatographyComplement C1medicineAnimalsHumansheterocyclic compoundsMolecular BiologybiologyChemistryAntibodies Monoclonalbiochemical phenomena metabolism and nutritionrespiratory systembacterial infections and mycosesMolecular biologyrespiratory tract diseasesC1 esteraseComplement C1 Inactivator ProteinsBiochemistryMonoclonalbiology.proteinAntibodyMolecular Immunology
researchProduct

PROBIOTICS: IN SICKNESS AND IN HEALTH

2018

Settore BIO/17 - IstologiaPROBIOTIC BACTEREMIA CANCER LACTOBACILLUS OPPORTUNISTIC INFECTIONS MICROBIOTA
researchProduct

Phosphatidylserine liposomes reduce inflammatory response, mycobacterial viability and HIV replication in coinfected human macrophages

2021

AbstractChronic immune activation is the key pathogenetic event of Mycobacterium tuberculosis-human immunodeficiency virus (HIV) coinfection. We assessed the therapeutic value of phosphatidylserine-liposome (PS-L) in an in vitro model of M. tuberculosis-HIV coinfection. PS-L reduced nuclear factor-κB activation and the downstream production of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and IL-6 in bacille Calmette-Guérin-infected macrophages and of TNF-α and IL-1β in M. tuberculosis-infected and M. tuberculosis-HIV–coinfected macrophages. Importantly, a significant reduction of intracellular M. tuberculosis viability and HIV replication were also observed. These results suppor…

Settore MED/04 - Patologia GeneraleTumor Necrosis Factor-alphaMacrophagesHIVHIV InfectionsMycobacterium tuberculosisPhosphatidylserinesVirus ReplicationSettore BIO/19Host-Directed TherapycoinfectionInfectious DiseasesLiposomesliposomeImmunology and AllergyHumansTuberculosisPhosphatidylserine
researchProduct

Molecular typing of Agrobacterium spp. isolates from catheter-related bloodstream infections

2004

Settore MED/07 - Microbiologia E Microbiologia ClinicaAgrobacterium spp. catheter-related bloodstream infections
researchProduct